Advertisement
Screener

Palvella Therapeutics, Inc. (PVLA) Material Contracts, 2014

Palvella Therapeutics, Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2014-12-23: Form 8-K; Exhibit 10.3; Description Form of Warrant to Purchase Common Stock, dated December 17, 2014, issued by Pieris Pharmaceuticals, Inc..
  • 2014-12-23: Form 8-K; Exhibit 10.2; Description Form of Registration Rights Agreement, dated December 17, 2014, by and among Pieris Pharmaceuticals, Inc. and the investors party thereto..
  • 2014-12-23: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated December 17, 2014, by and among Pieris Pharmaceuticals, Inc. and the Purchasers..
  • 2014-12-18: Form 8-K; Exhibit 10.34; Description General Release Agreement, by and among the Registrant, Marika Enterprises Inc. and Aleksandrs Sviks, dated December 17, 2014.
FiledFormExhibitDescription
2014-12-238-K10.3Form of Warrant to Purchase Common Stock, dated December 17, 2014, issued by Pieris Pharmaceuticals, Inc.
2014-12-238-K10.2Form of Registration Rights Agreement, dated December 17, 2014, by and among Pieris Pharmaceuticals, Inc. and the investors party thereto.
2014-12-238-K10.1Form of Securities Purchase Agreement, dated December 17, 2014, by and among Pieris Pharmaceuticals, Inc. and the Purchasers.
2014-12-188-K10.34General Release Agreement, by and among the Registrant, Marika Enterprises Inc. and Aleksandrs Sviks, dated December 17, 2014
2014-12-188-K10.33Split-Off Agreement, by and among the Registrant, Marika Enterprises Inc. and Aleksandrs Sviks, dated December 17, 2014
2014-12-188-K10.32Agreement, by and among Pieris AG and the Stockholders party thereto, dated December 5, 2014
2014-12-188-K10.31Investment Agreement, Pieris AG, Freising, Germany, by and among Pieris AG, Stephen Yoder and the Existing Shareholders party thereto, dated October 10, 2014
2014-12-188-K10.30Consolidated Shareholders’ Agreement 2014, Pieris AG, Freising, Germany, by and among Pieris AG and the Stockholders party thereto, dated October 10, 2014
2014-12-188-K10.29Convertible Bridge Loan Agreement by and among Pieris AG and the Stockholders listed on Exhibit A thereto, dated as of April 14, 2014
2014-12-188-K10.28Settlement Agreement (Accelerated Repayment Agreement) by and between Pieris AG and tbg Technologie-Beteiligungs-Gesellschaft mbH, dated as of December 11, 2014
2014-12-188-K10.27Repayment Agreement by and between Pieris AG and tbg Technologie-Beteiligungs-Gesellschaft mbH, dated as of April 3, 2014
2014-12-188-K10.26Participation Agreement (silent partnership agreement) between Pieris AG and tbg Technologie-Beteiligungs-Gesellschaft mbH, dated May 13, 2003
2014-12-188-K10.25Amendment to Convertible Bridge Loan Agreement by and among Pieris AG and the Stockholders listed therein, dated as of March 4, 2014
2014-12-188-K10.24Convertible Bridge Loan Agreement by and among Pieris AG and the Stockholder parties listed therein, dated as of November 12, 2012
2014-12-188-K10.23Lease Agreement by and between Pieris AG and Födergesellschft IZB mbH, dated as of May 4, 2011
2014-12-188-K10.22CONSULTING AGREEMENT
2014-12-188-K10.21Management Agreement
2014-12-188-K10.20Amendment to the
2014-12-188-K10.19Amendment to the
2014-12-188-K10.18Employment Agreement
2014-12-188-K10.17CONSULTING AGREEMENT
2014-12-188-K10.16Management Agreement
2014-12-188-K10.15EMPLOYMENT AGREEMENT
2014-12-188-K10.14Acknowledgement and Waiver Agreement
2014-12-188-K10.13AMENDED AND RESTATED MANAGEMENT AGREEMENT
2014-12-188-K10.12Amendment Agreement
2014-12-188-K10.11Management Agreement (the “Agreement”)
2014-12-188-K10.10Form of Indemnification Agreement by and between the Registrant and each of its current directors and executive officers
2014-12-188-K10.9RESEARCH AND LICENSING AGREEMENT
2014-12-188-K10.8JOINT DEVELOPMENT & LICENSE AGREEMENT
2014-12-188-K10.7DEVELOPMENT AND LICENSE AGREEMENT
2014-12-188-K10.6Collaboration Research and Technology Licensing Agreement
2014-12-188-K10.5Lise-Meitner-Straße
2014-12-188-K10.4COLLABORATION AND LICENSE AGREEMENT
2014-12-188-K10.3COLLABORATION AGREEMENT
2014-12-188-K10.22014 Employee, Director and Consultant Equity Incentive Plan
2014-12-188-K10.12014 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
Bausch Health Companies Inc. (BHC)$2.113B-1.68
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
Generate Biomedicines, Inc. (GENB)United States$2.052B
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12